Representative Lisa C. McClain (R-Michigan) recently sold shares of Zoetis Inc. NYSE: ZTS. In a filing disclosed on September 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Zoetis stock on August 4th. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.
Representative Lisa C. McClain also recently made the following trade(s):
- Sold $50,001 - $100,000 in shares of Taiwan Semiconductor Manufacturing NYSE: TSM on 8/28/2025.
- Purchased $1,001 - $15,000 in shares of ACI Worldwide NASDAQ: ACIW on 8/19/2025.
- Purchased $1,001 - $15,000 in shares of HCA Healthcare NYSE: HCA on 8/19/2025.
- Sold $1,001 - $15,000 in shares of Amedisys NASDAQ: AMED on 8/18/2025.
- Purchased $1,001 - $15,000 in shares of Kite Realty Group Trust NYSE: KRG on 8/13/2025.
- Sold $1,001 - $15,000 in shares of ServiceNow NYSE: NOW on 8/13/2025.
- Purchased $1,001 - $15,000 in shares of JD.com NASDAQ: JD on 8/13/2025.
- Sold $1,001 - $15,000 in shares of Trade Desk NASDAQ: TTD on 8/13/2025.
- Sold $1,001 - $15,000 in shares of US Foods NYSE: USFD on 8/13/2025.
- Purchased $1,001 - $15,000 in shares of Agree Realty NYSE: ADC on 8/13/2025.
Zoetis Trading Down 0.9%
Shares of NYSE:ZTS traded down $1.28 during trading on Friday, hitting $145.82. The company had a trading volume of 4,455,824 shares, compared to its average volume of 2,273,605. The stock has a market cap of $64.63 billion, a price-to-earnings ratio of 25.10, a price-to-earnings-growth ratio of 2.36 and a beta of 0.89. Zoetis Inc. has a one year low of $139.70 and a one year high of $197.51. The company has a fifty day simple moving average of $151.25 and a two-hundred day simple moving average of $156.59. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.76 and a quick ratio of 1.04.
Zoetis (NYSE:ZTS - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $1.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.62 by $0.14. The business had revenue of $2.46 billion during the quarter, compared to analyst estimates of $2.41 billion. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The company's revenue for the quarter was up 4.2% on a year-over-year basis. During the same period last year, the company earned $1.56 EPS. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, equities analysts forecast that Zoetis Inc. will post 6.07 earnings per share for the current year.
Analyst Upgrades and Downgrades
Several equities research analysts have recently issued reports on the company. Argus reaffirmed a "buy" rating and issued a $190.00 price objective on shares of Zoetis in a research note on Tuesday, September 9th. Leerink Partners downgraded Zoetis from an "outperform" rating to a "market perform" rating and reduced their price objective for the stock from $180.00 to $155.00 in a report on Thursday, July 17th. Piper Sandler raised their price objective on Zoetis from $210.00 to $215.00 and gave the stock an "overweight" rating in a report on Monday, August 11th. Stifel Nicolaus downgraded Zoetis from a "buy" rating to a "hold" rating and reduced their price objective for the stock from $165.00 to $160.00 in a report on Wednesday, June 18th. Finally, Leerink Partnrs downgraded Zoetis from a "strong-buy" rating to a "hold" rating in a report on Thursday, July 17th. Five analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $200.88.
Read Our Latest Report on Zoetis
Institutional Trading of Zoetis
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Nova Wealth Management Inc. acquired a new stake in Zoetis during the 1st quarter worth about $25,000. 1248 Management LLC acquired a new stake in Zoetis during the 1st quarter worth about $27,000. Saudi Central Bank acquired a new stake in Zoetis during the 1st quarter worth about $29,000. REAP Financial Group LLC lifted its holdings in shares of Zoetis by 201.5% in the 2nd quarter. REAP Financial Group LLC now owns 196 shares of the company's stock valued at $31,000 after buying an additional 131 shares during the period. Finally, Cornerstone Planning Group LLC lifted its holdings in shares of Zoetis by 79.3% in the 1st quarter. Cornerstone Planning Group LLC now owns 199 shares of the company's stock valued at $30,000 after buying an additional 88 shares during the period. Institutional investors and hedge funds own 92.80% of the company's stock.
About Representative McClain
Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.
McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election.
Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.
Zoetis Company Profile
(
Get Free Report)
Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.
Further Reading
Before you consider Zoetis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zoetis wasn't on the list.
While Zoetis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.